ES2310980B2 - USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. - Google Patents
USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. Download PDFInfo
- Publication number
- ES2310980B2 ES2310980B2 ES200702998A ES200702998A ES2310980B2 ES 2310980 B2 ES2310980 B2 ES 2310980B2 ES 200702998 A ES200702998 A ES 200702998A ES 200702998 A ES200702998 A ES 200702998A ES 2310980 B2 ES2310980 B2 ES 2310980B2
- Authority
- ES
- Spain
- Prior art keywords
- dracaena draco
- dracaena
- draco
- cream
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
- 241001448411 Dracaena draco Species 0.000 title claims abstract description 68
- 239000000284 extract Substances 0.000 title claims abstract description 26
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 239000006071 cream Substances 0.000 claims abstract description 17
- 235000014104 aloe vera supplement Nutrition 0.000 claims abstract description 6
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 5
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 5
- 239000000344 soap Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- 239000002453 shampoo Substances 0.000 claims description 5
- 208000035484 Cellulite Diseases 0.000 claims description 4
- 206010049752 Peau d'orange Diseases 0.000 claims description 4
- 206010040925 Skin striae Diseases 0.000 claims description 4
- 208000031439 Striae Distensae Diseases 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- 239000002781 deodorant agent Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002324 mouth wash Substances 0.000 claims description 4
- 229940051866 mouthwash Drugs 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- 239000002884 skin cream Substances 0.000 claims 2
- 239000000551 dentifrice Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 abstract description 13
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 210000004080 milk Anatomy 0.000 abstract description 4
- 235000013336 milk Nutrition 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract description 2
- 230000003370 grooming effect Effects 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 244000186892 Aloe vera Species 0.000 description 25
- 235000011399 aloe vera Nutrition 0.000 description 25
- 235000002961 Aloe barbadensis Nutrition 0.000 description 24
- 239000009136 dragon's blood Substances 0.000 description 23
- 239000011347 resin Substances 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 9
- 241001043298 Croton draco Species 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 241000894007 species Species 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 101000648554 Mus musculus Sushi domain-containing protein 6 Proteins 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- -1 clerodano Chemical compound 0.000 description 5
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 5
- 241000287219 Serinus canaria Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001448862 Croton Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 2
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 244000186071 dragons blood palm Species 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 2
- 239000008269 hand cream Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 229940109990 ruscogenin Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- MTAWKURMWOXCEO-UHFFFAOYSA-N taspine Chemical compound O1C(=O)C2=C(CCN(C)C)C=C(OC)C3=C2C2=C1C(OC)=CC=C2C(=O)O3 MTAWKURMWOXCEO-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- DXFSRFBWOGMMJP-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DXFSRFBWOGMMJP-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000741487 Croton draconoides Species 0.000 description 1
- 241001648676 Croton lechleri Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- FWKBXSPDFCAHFN-UHFFFAOYSA-N Dracorubin Natural products C1CC=2C(OC)=CC=3OC(C=45)=C(C)C(=O)C=C5OC(C=5C=CC=CC=5)=CC=4C=3C=2OC1C1=CC=CC=C1 FWKBXSPDFCAHFN-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000308676 Pterocarpus officinalis Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 description 1
- 229960005327 acemannan Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001796 anti-degenerative effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- DXHPZXWIPWDXHJ-UHFFFAOYSA-N carbon monosulfide Chemical compound [S+]#[C-] DXHPZXWIPWDXHJ-UHFFFAOYSA-N 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- OUKGCAYTOXHCFM-UHFFFAOYSA-N dracogenin Natural products OC1CCC2(O)C3CCC4C5CCC6(OCC(=C)C(O)C6O)OC5CC4C3CC=C2C1 OUKGCAYTOXHCFM-UHFFFAOYSA-N 0.000 description 1
- FWKBXSPDFCAHFN-DEOSSOPVSA-N dracorubin Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C(C)=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 FWKBXSPDFCAHFN-DEOSSOPVSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- YDURWQJGBGEELH-UHFFFAOYSA-N icogenin Natural products C1CC2(C)C3CCC4(C)C5C(C)C(OC)(CCC(C)CO)OC5CC4C3CC=C2CC1OC(C1OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O YDURWQJGBGEELH-UHFFFAOYSA-N 0.000 description 1
- YDURWQJGBGEELH-KEHPPEEVSA-N icogenin Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]([C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)(CC[C@H](C)CO)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YDURWQJGBGEELH-KEHPPEEVSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VNLRTFSQCPNNIM-UHFFFAOYSA-N octadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC VNLRTFSQCPNNIM-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940073741 steareth-7 Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000037316 sun-exposed skin Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- RKEBJJCZAOFMLH-UHFFFAOYSA-N taspine Natural products COc1ccc2OC(=O)c3c(OC)cc(CN(C)C)c4OC(=O)c1c2c34 RKEBJJCZAOFMLH-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Uso de extractos de Dracaena draco en la preparación de productos cosméticos.Use of Dracaena draco extracts in the preparation of cosmetic products.
La presente invención se adscribe al sector industrial de la obtención de extractos naturales de plantas, en concreto del árbol de Canarias Dracaena draco, para su uso en sectores industriales de aplicación a la cosmética y aseo. En concreto se describen diferentes formulaciones cosméticas en forma de cremas, leches hidratantes, geles, protectores solares, etc., basadas en extractos Dracaena draco, opcionalmente combinados con extractos de Aloe vera.The present invention is attached to the industrial sector of obtaining natural plant extracts, specifically from the Dracaena draco Canarian tree, for use in industrial sectors of application to cosmetics and grooming. Specifically, different cosmetic formulations are described in the form of creams, moisturizing milks, gels, sunscreens, etc., based on Dracaena draco extracts, optionally combined with Aloe vera extracts.
Description
Uso de extractos de Dracaena draco en la preparación de productos cosméticos.Use of Dracaena draco extracts in the preparation of cosmetic products.
La presente invención se adscribe al sector industrial de la obtención de extractos naturales de plantas, en concreto del árbol de Canarias Dracaena draco, para su uso en sectores industriales de aplicación a la cosmética.The present invention is attached to the industrial sector of obtaining natural plant extracts, specifically from the Dracaena draco Canarian tree, for use in industrial sectors applicable to cosmetics.
Dracaena draco, también llamado drago canario, es un árbol cuya madera se ha utilizado tradicionalmente en artesanía principalmente de carácter ornamental. Sus hojas se han utilizado también como forraje para la cabaña ganadera, fundamentalmente caprina, de las islas Canarias. La base anaranjada de las hojas se ha utilizado como curtiente, tinte o colorante, generalmente mediante picado o triturado de las mismas, o a partir de infusiones de dichas hojas. También para este tipo de aplicaciones relacionadas con la aplicación de color, se ha utilizado la resina de color rojizo del drago canario. Es lo que se ha denominado "sangre de dragón" o "sangre de drago". Esta sangre de dragón se ha llegado a utilizar como remedio medicinal tradicional contra la tos, como fortalecedor de las encías, como antinflamatorio y también como antiulceroso. La denominación de sangre de dragón se aplica a productos extraídos de muy diferentes plantas y con composiciones muy diferentes entre ellas, pero que todas tienen un rasgo común, su color rojo, de ahí su denominación. Dracaena draco , also called canary drago, is a tree whose wood has traditionally been used in crafts mainly of an ornamental nature. Its leaves have also been used as fodder for the cattle cabin, mainly goats, of the Canary Islands. The orange base of the leaves has been used as tanning, dyeing or coloring, generally by chopping or crushing them, or from infusions of said leaves. Also for this type of applications related to the application of color, the reddish resin of the canary drago has been used. It is what has been called "dragon blood" or "dragon blood". This dragon blood has come to be used as a traditional medicinal remedy against cough, as a gum enhancer, as an anti-inflammatory and also as an antiulcer. The designation of dragon blood is applied to products extracted from very different plants and with very different compositions between them, but all of them have a common feature, their red color, hence their denomination.
Los componentes químicos más comúnmente citados, presentes en esta especie arbórea son las flavonas y las sapogeninas, entre las que se pueden citar: dracogenina, diosgenina, ruscogenina y dihidrosansevierigenina.The most commonly cited chemical components, present in this tree species are flavones and sapogenins, among which we can mention: dracogenin, Diosgenin, ruscogenin and dihydrosansevierigenin.
Sin embargo, bajo la denominación de sangre de drago, se identifican extractos de otras plantas, del tipo de las palmas. La sangre de dragón de esta otra especie arbórea (la palma) se utiliza como astringente en hemorragias y diarreas y, en medicina china, se utiliza el látex de la palma para el tratamiento del cáncer de útero. También se ha empleado como ingrediente en colirios.However, under the denomination of blood of drago, extracts of other plants are identified, of the type of palms Dragon's blood of this other tree species (palm) It is used as an astringent in hemorrhages and diarrhea and, in medicine China, palm latex is used for the treatment of uterine cancer. It has also been used as an ingredient in eye drops
Existen otras especies con similares propiedades astringentes a la sangre de dragón obtenida de Daemonorops draco, tales como Pterocarpus draco L.. Esta leguminosa tiene una savia rojiza que, además de cómo astringente, se emplea también como desinfectante y bacteriostático por las comunidades indígenas de Iberoamérica. En estas comunidades se emplea como una especie de mercromina vegetal, llegándose a tratar con ella, hasta las úlceras gastroduodenales.There are other species with similar astringent properties to dragon blood obtained from Daemonorops draco , such as Pterocarpus draco L. This legume has a reddish sap that, in addition to being an astringent, is also used as a disinfectant and bacteriostatic by the indigenous communities of Latin America . In these communities it is used as a kind of vegetable mercromine, getting to deal with it, up to gastroduodenal ulcers.
Otra familia que se utiliza para fabricar sangre de dragón es el Croton. Dentro de esta familia existen diferentes especies utilizadas para extraer sangre de dragón. Entre ellas podemos citar: Croton draco Schlecht, Croton draconoides, Croton erythrochilus, Croton huitorum, Crotum palanostigma y Crotum perpeciosus. Pero quizás la especie de esta familia más caracterizada en cuanto a la composición de su sangre de dragón sea Croton Lechleri Muell. La sangre de dragón de esta especie contiene, entre otros, los siguientes componentes: alcaloides como la taspina, diterpenoides como el clerodano, korberinas, beta-sistosterol, lignanos, derivados gálicos y catéquicos, proantocianidósidos, etc.. La sangre de dragón de esta especie se utiliza también como astringente hemostático y antidiarreico, pero también como cicatrizante de heridas y quemaduras, antinflamatorio y antitumoral. Además es utilizado también como antibacteriano o antivírico.Another family that is used to make dragon blood is the Croton. Within this family there are different species used to draw dragon blood. Among them we can mention: Croton draco Schlecht , Croton draconoides , Croton erythrochilus , Croton huitorum , Crotum palanostigma and Crotum perpeciosus . But perhaps the species of this family most characterized in terms of the composition of its dragon blood is Croton Lechleri Muell . Dragon blood of this species contains, among others, the following components: alkaloids such as taspine, diterpenoids such as clerodano, korberinas, beta-sistosterol, lignans, gallic and catholic derivatives, proanthocyanidides, etc. .. The dragon blood of this The species is also used as a hemostatic and anti-diarrheal astringent, but also as a wound and burn scar, anti-inflammatory and anti-tumor. In addition it is also used as an antibacterial or antiviral.
Como clara indicación de las diferencias existentes entre las composiciones de los diferentes tipos de sangre de dragón existentes resaltar que, por ejemplo, frente a la composición química cualitativa de los componentes más representativos existentes en la sangre de dragón extraída de Dracaena draco, anteriormente mencionada, la composición cualitativa de los componentes más representativos de la sangre de dragón extraída de Daemonorops draco, no presenta coincidencia alguna. Entre los componentes de esta otra sangre de dragón, podemos citar: draconina, dracoalbano, dracorubina, antocianidinas como la dracocarmina, dracorubocorhodina, ácido abiótico, etc...As a clear indication of the differences between the compositions of the different types of existing dragon blood, it should be noted that, for example, compared to the qualitative chemical composition of the most representative components in the dragon blood extracted from Dracaena draco , mentioned above, The qualitative composition of the most representative components of dragon blood extracted from Daemonorops draco , does not show any coincidence. Among the components of this other dragon blood, we can mention: draconine, dracoalbano, dracorubin, anthocyanidins such as dracocarmine, dracorubocorhodine, abiotic acid, etc ...
Las diferencias existentes entre las diferentes composiciones químicas cualitativas de las distintas sangres de dragón extraídas de variadas plantas, existentes en el mercado o empleadas tradicionalmente por las diferentes comunidades indígenas, va a determinar, por consiguiente, las diferentes propiedades que dichas composiciones presenten y las diferentes aplicaciones o indicaciones en las que puedan ser empleadas.The differences between the different qualitative chemical compositions of the different bloods of dragon extracted from various plants, existing in the market or traditionally used by different indigenous communities, will determine, therefore, the different properties that said compositions present and the different applications or indications in which they can be used.
Existen usos patentados de compuestos específicos aislados de Dracaena draco, como el uso de una propanona sustituida con tetrafenol en el tratamiento del cáncer (JP20066241078) al inducir la apoptosis de las células cancerígenas. También ha sido puesto de manifiesto el efecto en determinadas líneas tumorales de algunos compuestos químicos aislados de Dracaena draco, como por ejemplo las saponinas y en particular una de ellas, la icogenina sobre línea celulares de leucemia mieloide (1, 2, 3). Dichos compuestos fueron generalmente aislado de las hojas del árbol, aunque también se han descrito otros, las dracogeninas, que se han aislado del tronco (4).There are patented uses of specific compounds isolated from Dracaena draco , such as the use of a propanone substituted with tetraphenol in the treatment of cancer (JP20066241078) by inducing apoptosis of cancer cells. The effect on certain tumor lines of some chemical compounds isolated from Dracaena draco , such as saponins and in particular one of them, icogenin on myeloid leukemia cell lines (1, 2, 3) has also been revealed. These compounds were generally isolated from the leaves of the tree, although others have also been described, dracogenins, which have been isolated from the trunk (4).
Ninguna de las composiciones de sangre de dragón procedentes de Dracaena draco descritas hasta la fecha en el estado de la técnica han sido utilizadas para los usos objeto de la presente invención.None of the dragon blood compositions from Dracaena draco described to date in the state of the art have been used for the uses object of the present invention.
Una realización preferida de la presente invención es el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de aplicación tópica para el tratamiento posterior de la piel expuesta al sol.A preferred embodiment of the present invention is the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of a topical application for the subsequent treatment of sun-exposed skin.
Otra realización de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de crema o de leche hidratante de aplicación tópica, útiles para la hidratación de la piel. De forma análoga, otra realización de la invención consiste en el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de crema de aplicación tópica, útiles para el tratamiento reafirmante y mejorador de la elasticidad de la piel. En esta misma línea, otra realización de la presente invención consiste en el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de crema de aplicación tópica, útiles para el tratamiento renovador y nutritivo de la piel. Dentro de este conjunto de aplicaciones, otra realización de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de crema de aplicación tópica, útiles para reducir el efecto de envejecimiento producido por la exposición de la piel de zonas del cuerpo tales como: cara, cuello y manos, al medio ambiente.Another embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of a cream or a topical application moisturizing milk, useful for skin hydration. Similarly, another embodiment of the invention consists in the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of topically applied cream, useful for the firming and improving treatment of skin elasticity. In this same line, another embodiment of the present invention consists in the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of topically applied cream, useful for the skin's refreshing and nourishing treatment. Within this set of applications, another embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of topically applied cream, useful for reducing the aging effect produced by the exposure of the skin of areas of the body such as: face, neck and hands, to the environment.
Una nueva realización de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de composiciones, por ejemplo en forma de gel, particularmente para aplicación tópica en sesiones de masaje, útiles para relajar músculos, tendones y articulaciones, debido a que al absorberse producen una grata sensación de frío-calor.A new embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of compositions, for example in the form of a gel, particularly for topical application in massage sessions, useful for relaxing muscles, tendons and joints, due to that when absorbed produce a pleasant sensation of cold-heat.
Otra realización de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de jabones y champús. En el primer caso en forma de jabones sólidos, con excelentes propiedades bactericidas que lo hacen muy útil, además de para limpiar la superficie corporal, para prevenir y combatir el acné. En el caso del champú, a su efecto limpiador del cabello y del cuero cabelludo, se une su control de la secreción de grasa y la aparición de caspa.Another embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of soaps and shampoos. In the first case in the form of solid soaps, with excellent bactericidal properties that make it very useful, in addition to cleaning the body surface, to prevent and combat acne. In the case of shampoo, to its hair and scalp cleansing effect, its control of fat secretion and the appearance of dandruff is combined.
Una realización adicional de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de aplicación tópica, útiles como protectores solares, durante la exposición solar de la piel al mismo. Otra realización de la invención es el uso de extractos de resina de Dracaena draco, para la fabricación de cosméticos, particularmente en forma de aplicación tópica, útiles para el tratamiento de la celulitis o para evitar las estrías de la piel originadas por causas diversas.A further embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of topical application, useful as sunscreens, during sun exposure of the skin thereto. Another embodiment of the invention is the use of Dracaena draco resin extracts, for the manufacture of cosmetics, particularly in the form of a topical application, useful for the treatment of cellulite or to avoid skin stretch marks caused by various causes.
Todos los usos de la invención anteriormente mencionados se basan bien en composiciones con únicamente extracto de Dracaena draco como único principio activo responsable de los usos objeto de la presente invención, bien se combinan sinérgicamente con un extracto de Aloe vera.All of the above-mentioned uses of the invention are based either on compositions with Dracaena draco extract only as the sole active principle responsible for the uses object of the present invention, or are combined synergistically with an Aloe vera extract.
El aloe actúa como vehículo de otros activos, en este caso de la sangre de drago. Tiene la cualidad de penetrar y hacer penetrar desde la piel o las mucosas hasta el torrente sanguíneo sus principios activos y los de cualquier otro extracto asociado al mismo en una composición.Aloe acts as a vehicle for other assets, in This case of the dragon's blood. It has the quality of penetrating and make penetrate from the skin or mucous membranes to the torrent blood its active ingredients and those of any other extract associated with it in a composition.
A los efectos de la presente invención el término extracto de Dracaena draco es una solución de resina de drago canario, también llamada sangre de drago.For the purposes of the present invention the term Dracaena draco extract is a solution of Canarian dragon resin, also called dragon's blood.
Las resinas en general son productos de constitución compleja. Son sustancias amorfas, duras a la temperatura ordinaria, pero se licuan por el calor, haciéndose transparentes o translúcidas y brillantes a la rotura.Resins in general are products of complex constitution. They are amorphous substances, hard to ordinary temperature, but they are liquefied by heat, becoming transparent or translucent and bright to breakage.
La resina sangre de drago se presenta en forma de masas rojo oscuras, casi negruzcas, de color rojo carmín, de fractura concoidea y vítrea. Soluble en alcohol, cloroformo, sulfuro de carbono, bencina, aceites esenciales oxigenados, álcalis cáusticos, trietanolamina y propilenglicol.The dragon blood resin comes in the form dark red masses, almost blackish, carmine red, of concoid and vitreous fracture. Soluble in alcohol, chloroform, carbon sulfide, benzine, oxygenated essential oils, alkalis caustics, triethanolamine and propylene glycol.
Para ser añadido a formulaciones es necesario licuar el producto (p.e. calor), pulverizarlo, atomizarlo o disolverlo previamente en alguno de sus solventes. Su cuantificación depende de la zona de cultivo, de la edad de la planta y de la época del año en que se obtiene.To be added to formulations it is necessary liquefy the product (e.g. heat), spray it, spray it or dissolve it previously in any of its solvents. its quantification depends on the cultivation area, on the age of the plant and the time of the year in which it is obtained.
La resina o sangre de drago que se añade en las diferentes composiciones que se citan a continuación como ejemplos no limitativos del alcance de la invención, se añade en solución, excepto en presentación relativa a las cápsulas, tabletas o comprimidos, en las que se añade en forma de polvo seco.The resin or blood of drago that is added in the different compositions cited below as examples not limiting the scope of the invention, is added in solution, except in presentation concerning capsules, tablets or tablets, in which it is added as dry powder.
De la presencia de sapogeninas, especialmente la ruscogenina y de isoflavonas en la composición de la sangre de drago se derivan de forma sorprendente propiedades antioxidantes para las células, lo que conlleva, cuando las células son epidérmicas, efectos regenerativos de la piel si se aplica vía tópica y, cuando se ingiere en forma de bebidas, alimentos o aditivos nutricionales o dietéticos, una menor muerte celular, lo que conlleva efectos antidegenerativos y antienvejecimiento del organismo y un efecto general vigorizante y tonificante en general.Of the presence of sapogenins, especially the ruscogenin and isoflavones in the blood composition of drago are surprisingly derived antioxidant properties for the cells, which entails, when the cells are epidermal, regenerative effects of the skin if applied via topical and, when ingested in the form of drinks, food or nutritional or dietary additives, lower cell death, what which entails antidegenerative and anti-aging effects of organism and a general invigorating and invigorating effect on general.
Es un objeto preferido de la presente invención el uso de la sangre de drago como ingrediente de composiciones cosméticas o de aseo, entre otras: geles de ducha, cremas hidratantes, dentífricos, lápiz de labios, lociones para después del afeitado, desodorantes, jabones, etc. Además de su acción antioxidante, la sangre de drago debido a su composición, tiene otros efectos sinérgicos a aquél que la hacen especialmente indicada para otras aplicaciones cosméticas. Por ejemplo, su acción astringente y reforzadora de las encías, unidas a su efecto antioxidante anteriormente mencionado, la hacen un ingrediente idóneo en composiciones de colutorios.It is a preferred object of the present invention the use of dragon's blood as an ingredient of compositions cosmetic or grooming, among others: shower gels, creams moisturizers, toothpastes, lipstick, after-lotion shaving, deodorants, soaps, etc. In addition to its action antioxidant, the dragon's blood due to its composition, has other synergistic effects that make it especially indicated for other cosmetic applications. For example, your action astringent and gum enhancer, together with its effect antioxidant mentioned above, make it an ingredient suitable in mouthwash compositions.
Otro objeto de la presente invención consiste en suplementar las composiciones cosméticas que comprenden como ingrediente sangre de drago, con un extracto de Aloe vera. A los efectos de la presente invención el extracto de Aloe vera es un gel extraído de las hojas.Another object of the present invention is to supplement cosmetic compositions comprising as an ingredient dragon's blood, with an extract of Aloe vera . For the purposes of the present invention, Aloe Vera extract is a gel extracted from the leaves.
La sangre de drago es una resina compuesta por (%, si no se indica otra unidad):Dragon's blood is a resin composed of (%, if no other unit is indicated):
Las cantidades expresadas en las siguientes fórmulas se entienden son partes de sangre de Dracaena draco puro antes de ser disueltas en cualquier solvente.The amounts expressed in the following formulas are understood as parts of Dracaena draco pure blood before being dissolved in any solvent.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
- \bullet?
- Carbomer (nombre INCI) es un carbómero cuya función es estabilizador de emulsiones. Agente controlador de la viscosidad. Con la marca Carbopol® se comercializa como espesante y se ajusta la viscosidad controlando el pH con trietanolamina o hidróxido sódico (NaOH).Carbomer (name INCI) is a carbomer whose function is emulsion stabilizer. Agent viscosity controller. With the Carbopol® brand you marketed as a thickener and the viscosity is adjusted by controlling the pH with triethanolamine or sodium hydroxide (NaOH).
- ^{(1)}<1>
- La base autoemulsionante de todos los ejemplos donde se cita como tal, se compone de los siguientes ingredientes (Composición INCI de la base autoemulsionable Neopcl):Estearil heptanoato, cetearil etilhexanoato, cetil palmitato, alcohol estearílico, steareth-7, steareth-10, estearil caprilato, isopropil L miristato, alcohol Mirístico, dimeticona.Everyone's self-emulsifying base the examples where it is cited as such, is composed of the following Ingredients (INCI composition of the self-emulsifying base Neopcl): Stearyl heptanoate, cetearyl ethylhexanoate, cetyl palmitate, stearyl alcohol, steareth-7, steareth-10, stearyl caprylate, isopropyl L myristate, myristic alcohol, dimethicone.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El Aloe vera (Linneo), también llamado Aloe barbadensis (Mill) a añadir como ingrediente en las diferentes composiciones de la presente invención, de forma conjunta con el extracto de Dracaena draco, se añade en forma de gel puro. El gel puro es extraído de las hojas maduras de Aloe vera y estabilizado a temperatura ambiente para no dañar activos termolábiles. Resulta un líquido gelatinoso característico. Aloe vera (Linnaeus), also called Aloe barbadensis (Mill) to be added as an ingredient in the different compositions of the present invention, together with Dracaena draco extract, is added as a pure gel. The pure gel is extracted from the mature Aloe vera leaves and stabilized at room temperature so as not to damage thermolabile assets. It is a characteristic gelatinous liquid.
El gel de Aloe vera está compuesto por un 95%-99% de agua y el resto por unos 200 elementos entre los que destacan las antraquinonas, que son eliminadas en los jugos de beber por su efecto laxante, monosacáridos y polisacáridos especialmente el acemanano, específico del Aloe vera en el reino vegetal; 18 aminoácidos incluyendo los ocho esenciales; enzimas, minerales, incluyendo el germanio y vitaminas. Aloe vera gel is composed of 95% -99% water and the rest by about 200 elements among which anthraquinones, which are eliminated in drinking juices due to their laxative effect, monosaccharides and polysaccharides especially acemannan, Aloe vera specific in the plant kingdom; 18 amino acids including the eight essentials; enzymes, minerals, including germanium and vitamins.
El Aloe vera es una planta holística que necesita de la acción de todos sus componentes para mostrar su mejor efectividad. Su cuantificación depende de la zona de cultivo, de la edad de la planta y de la época del año de recolección. Las plantas de Aloe vera en Canarias concentran hasta 600 veces más de algunos principio activos que plantas de otras latitudes del mundo. Aloe vera is a holistic plant that needs the action of all its components to show its best effectiveness. Its quantification depends on the cultivation area, the age of the plant and the time of the year of collection. Aloe vera plants in the Canary Islands concentrate up to 600 times more of some active ingredients than plants in other latitudes of the world.
1.- Yoshihiro, M. et al; Phytochemistry (1999); 50 (5): 805-813.1.- Yoshihiro , M. et al ; Phytochemistry ( 1999 ); 50 (5): 805-813.
2.- Hernández J.C. et al. Bioorganic & Medicinal Chemistry (2004); 12 (16): 4423-4429.2.- Hernández JC et al . Bioorganic & Medicinal Chemistry ( 2004 ); 12 (16): 4423-4429.
3.- Hernández J.C.; Chemistry & Biodiversity (2006); 3 (1): 62-68.3.- Hernández JC; Chemistry & Biodiversity ( 2006 ); 3 (1): 62-68.
4.- González, A.G.; J. Natural Products (2003); 66 (6): 793-798.4.- González , AG; J. Natural Products ( 2003 ); 66 (6): 793-798.
Claims (5)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702998A ES2310980B2 (en) | 2007-11-13 | 2007-11-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. |
| ES200800741A ES2328890B1 (en) | 2007-11-13 | 2008-03-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF DIETETIC AND NUTRITIONAL PRODUCTS. |
| PCT/ES2008/000695 WO2009063105A1 (en) | 2007-11-13 | 2008-11-10 | Use of extracts of dracaena draco in the preparation of pharmaceutical, cosmetic, dietetic and nutritional products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702998A ES2310980B2 (en) | 2007-11-13 | 2007-11-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2310980A1 ES2310980A1 (en) | 2009-01-16 |
| ES2310980B2 true ES2310980B2 (en) | 2009-08-13 |
Family
ID=40192866
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200702998A Withdrawn - After Issue ES2310980B2 (en) | 2007-11-13 | 2007-11-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. |
| ES200800741A Expired - Fee Related ES2328890B1 (en) | 2007-11-13 | 2008-03-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF DIETETIC AND NUTRITIONAL PRODUCTS. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200800741A Expired - Fee Related ES2328890B1 (en) | 2007-11-13 | 2008-03-13 | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF DIETETIC AND NUTRITIONAL PRODUCTS. |
Country Status (1)
| Country | Link |
|---|---|
| ES (2) | ES2310980B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114917166B (en) * | 2022-04-28 | 2023-08-11 | 澳宝化妆品（惠州）有限公司 | Dragon blood tree fruit extract, shower gel composition thereof, application and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006241078A (en) * | 2005-03-03 | 2006-09-14 | Kiyoteru Tobinaga | New tetraphenol-substituted propanone compound and granulation-promoting agent containing the same as active ingredient and cancer cell apoptosis-inducing agent |
-
2007
- 2007-11-13 ES ES200702998A patent/ES2310980B2/en not_active Withdrawn - After Issue
-
2008
- 2008-03-13 ES ES200800741A patent/ES2328890B1/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006241078A (en) * | 2005-03-03 | 2006-09-14 | Kiyoteru Tobinaga | New tetraphenol-substituted propanone compound and granulation-promoting agent containing the same as active ingredient and cancer cell apoptosis-inducing agent |
Non-Patent Citations (2)
| Title |
|---|
| GUPTA, D. et al. "{}Dragon's blood: Botany, chemistry and therapeutic uses"{}. Journal of Ethnopharmacology, 2008. Vol. 115, páginas 361 - 380. Disponible online 22.10.2007. ISSN 0378-8741. Ver página 362, columna 2, "{}1.2 Historical uses"{}, primer párrafo; página 374. * |
| SPARG, S. G. et al."{}Biological activities and distribution of plant saponins"{}. Journal of Ethnopharmacology, 2004. Vol. 94, n$^{o}$ 2 - 3, páginas 219 - 243. ISSN 0378-8741. Ver página 219, columna 1 y página 231, Tabla 1, "{}Dracaenaceae: Dracaena draco"{}. * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2328890A1 (en) | 2009-11-18 |
| ES2310980A1 (en) | 2009-01-16 |
| ES2328890B1 (en) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2972379T3 (en) | Compositions including extracts of ampelopsis grossedentata and albizia julibrissin and methods of use | |
| ES2665313T3 (en) | Passionflower seed extract and cosmetic, pharmaceutical, dermatological or nutraceutical compositions comprising it | |
| ES2700784T3 (en) | Extract of aerial parts of Gynandropsis gynandra or Cleome gynandra and cosmetic, dermatological or pharmaceutical compositions comprising it | |
| ES2617759T3 (en) | Use of compositions comprising paulownin and / or paulownia extracts | |
| US9168279B2 (en) | Compositions comprising paulownin and/or Paulownia extracts and uses thereof | |
| Patil et al. | A review on: standerdization of herb in new era of cosmaceuticals: herbal cosmetics | |
| ES2960038T3 (en) | Moringa peregrina seed extract rich in 2,5-diformylfuran, procedure for obtaining it and its use in cosmetic compositions | |
| ES2564157T3 (en) | Compositions comprising extracts of Bursera simaruba | |
| CN106344458A (en) | Whitening cream containing ginseng and cornu cervi pantotrichum | |
| CN106333886A (en) | Composition having moisture preserving and skin whitening and brightening effects and application thereof | |
| BR102014025813A2 (en) | compositions comprising paulownia tomentosa wood extracts and uses thereof | |
| ES2310980B2 (en) | USE OF DRACAENA DRACO EXTRACTS IN THE PREPARATION OF COSMETIC PRODUCTS. | |
| TW201231086A (en) | Compositions comprising Lilium siberia extracts and uses thereof | |
| ES2638298T3 (en) | Complex of plant extracts for skin protection | |
| WO2009063105A1 (en) | Use of extracts of dracaena draco in the preparation of pharmaceutical, cosmetic, dietetic and nutritional products | |
| JP6823938B2 (en) | Topical skin agent | |
| CN109745262A (en) | A kind of composition for Whitening, spot face cream | |
| Garad et al. | Formulation and evaluation of multiuse polyherbal face scrub | |
| Krishnan et al. | FORMULATION AND EVALUTION OF HERBAL VANISHING CREAM | |
| CA3017488A1 (en) | Cosmetic electro-acupuncture without needles and corneotherapy beauty treatment | |
| Somwanshi et al. | Cosmetic Science | |
| RU2755199C1 (en) | Washing foam | |
| Mathesvaran et al. | FORMULATION AND EVALUATION OF ANTI-AGING POLYHERBAL COSMETIC FACE CREAM | |
| Asthana et al. | " NATURAL SYNERGY IN SKINCARE: POLYHERBAL FACE SERUM COMPOSITION AND ITS APPLICATIONS | |
| CN118845513A (en) | A moisturizing and skin-lightening composition and essence containing the composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20090116 Kind code of ref document: A1 |
|
| FA2A | Application withdrawn |
Effective date: 20121030 |